FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049521952> ?p ?o ?g. }

• W2049521952 endingPage "943" @default.
• W2049521952 startingPage "932" @default.
• W2049521952 abstract "After the rapid development of new classes of antineoplastic drugs, research activities have focused their efforts to the identification of predictive markers of drug activity and tolerability. Irinotecan (CPT-11) may induce severe toxicities (diarrhea, neutropenia) that limit its clinical use, but the increasing knowledge of its pharmacokinetics offered a potential approach to treatment optimization. Pharmacokinetics, the first area of investigation, has identified markers such as biliary index, the relative extent of conversion and the glucuronidation ratio, which are capable to define the risk for severe adverse effects. Because of the existence of some issues concerning the adoption of pharmacokinetic strategies to optimize CPT-11 dose and schedule, analyses of genetic polymorphisms seemed to offer a more reliable and safer approach for the identification of patients at risk than pharmacokinetics. In this view, the uridine diphosphate glucuronosil transferase isoform 1A1 (UGT1A1) was associated with significant changes in disposition of CPT-11 and its metabolites, and consequently with treatment-induced toxicities. However, the complex pharmacokinetics of irinotecan and the involvement of several enzymes other than UGT (i.e., carboxyl estherases, CYP450 isoforms), and transmembrane transporters (ABCB1, ABCC1, ABCG2, SLCO1B1) make difficult the identification of patients with an optimal sensitivity and specificity, and a large part of variability among patients still remains unexplained. Furthermore, prospective clinical studies that should demonstrate the reliability of those pharmacokinetic and pharmacogenetic markers are still lacking. In the present review, pharmacokinetic and pharmacogenetic markers will be discussed. Keywords: Irinotecan, pharmacokinetics, pharmacogenetics, toxicity, effectiveness, metabolite, plasma, cytotoxic, predictive markers" @default.
• W2049521952 created "2016-06-24" @default.
• W2049521952 creator A5003913815 @default.
• W2049521952 creator A5006108984 @default.
• W2049521952 creator A5025020524 @default.
• W2049521952 creator A5030848899 @default.
• W2049521952 creator A5033055161 @default.
• W2049521952 creator A5083693387 @default.
• W2049521952 creator A5084400647 @default.
• W2049521952 date "2011-12-01" @default.
• W2049521952 modified "2023-10-16" @default.
• W2049521952 title "Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity" @default.
• W2049521952 doi "https://doi.org/10.2174/138920011798062283" @default.
• W2049521952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21787264" @default.
• W2049521952 hasPublicationYear "2011" @default.
• W2049521952 type Work @default.
• W2049521952 sameAs 2049521952 @default.
• W2049521952 citedByCount "47" @default.
• W2049521952 countsByYear W20495219522012 @default.
• W2049521952 countsByYear W20495219522013 @default.
• W2049521952 countsByYear W20495219522014 @default.
• W2049521952 countsByYear W20495219522015 @default.
• W2049521952 countsByYear W20495219522016 @default.
• W2049521952 countsByYear W20495219522017 @default.
• W2049521952 countsByYear W20495219522018 @default.
• W2049521952 countsByYear W20495219522019 @default.
• W2049521952 countsByYear W20495219522020 @default.
• W2049521952 countsByYear W20495219522021 @default.
• W2049521952 countsByYear W20495219522022 @default.
• W2049521952 countsByYear W20495219522023 @default.
• W2049521952 crossrefType "journal-article" @default.
• W2049521952 hasAuthorship W2049521952A5003913815 @default.
• W2049521952 hasAuthorship W2049521952A5006108984 @default.
• W2049521952 hasAuthorship W2049521952A5025020524 @default.
• W2049521952 hasAuthorship W2049521952A5030848899 @default.
• W2049521952 hasAuthorship W2049521952A5033055161 @default.
• W2049521952 hasAuthorship W2049521952A5083693387 @default.
• W2049521952 hasAuthorship W2049521952A5084400647 @default.
• W2049521952 hasConcept C104317684 @default.
• W2049521952 hasConcept C112705442 @default.
• W2049521952 hasConcept C121608353 @default.
• W2049521952 hasConcept C126322002 @default.
• W2049521952 hasConcept C135763542 @default.
• W2049521952 hasConcept C140840227 @default.
• W2049521952 hasConcept C143998085 @default.
• W2049521952 hasConcept C149151106 @default.
• W2049521952 hasConcept C181199279 @default.
• W2049521952 hasConcept C2779907587 @default.
• W2049521952 hasConcept C2780035454 @default.
• W2049521952 hasConcept C2780259306 @default.
• W2049521952 hasConcept C526171541 @default.
• W2049521952 hasConcept C526805850 @default.
• W2049521952 hasConcept C55493867 @default.
• W2049521952 hasConcept C55775858 @default.
• W2049521952 hasConcept C62231903 @default.
• W2049521952 hasConcept C71924100 @default.
• W2049521952 hasConcept C86803240 @default.
• W2049521952 hasConcept C87644729 @default.
• W2049521952 hasConcept C98274493 @default.
• W2049521952 hasConceptScore W2049521952C104317684 @default.
• W2049521952 hasConceptScore W2049521952C112705442 @default.
• W2049521952 hasConceptScore W2049521952C121608353 @default.
• W2049521952 hasConceptScore W2049521952C126322002 @default.
• W2049521952 hasConceptScore W2049521952C135763542 @default.
• W2049521952 hasConceptScore W2049521952C140840227 @default.
• W2049521952 hasConceptScore W2049521952C143998085 @default.
• W2049521952 hasConceptScore W2049521952C149151106 @default.
• W2049521952 hasConceptScore W2049521952C181199279 @default.
• W2049521952 hasConceptScore W2049521952C2779907587 @default.
• W2049521952 hasConceptScore W2049521952C2780035454 @default.
• W2049521952 hasConceptScore W2049521952C2780259306 @default.
• W2049521952 hasConceptScore W2049521952C526171541 @default.
• W2049521952 hasConceptScore W2049521952C526805850 @default.
• W2049521952 hasConceptScore W2049521952C55493867 @default.
• W2049521952 hasConceptScore W2049521952C55775858 @default.
• W2049521952 hasConceptScore W2049521952C62231903 @default.
• W2049521952 hasConceptScore W2049521952C71924100 @default.
• W2049521952 hasConceptScore W2049521952C86803240 @default.
• W2049521952 hasConceptScore W2049521952C87644729 @default.
• W2049521952 hasConceptScore W2049521952C98274493 @default.
• W2049521952 hasIssue "10" @default.
• W2049521952 hasLocation W20495219521 @default.
• W2049521952 hasLocation W20495219522 @default.
• W2049521952 hasOpenAccess W2049521952 @default.
• W2049521952 hasPrimaryLocation W20495219521 @default.
• W2049521952 hasRelatedWork W1996694250 @default.
• W2049521952 hasRelatedWork W2049521952 @default.
• W2049521952 hasRelatedWork W2058965590 @default.
• W2049521952 hasRelatedWork W2082453691 @default.
• W2049521952 hasRelatedWork W2095125338 @default.
• W2049521952 hasRelatedWork W2240990962 @default.
• W2049521952 hasRelatedWork W2261898534 @default.
• W2049521952 hasRelatedWork W3003305233 @default.
• W2049521952 hasRelatedWork W3173651342 @default.
• W2049521952 hasRelatedWork W570547535 @default.
• W2049521952 hasVolume "12" @default.
• W2049521952 isParatext "false" @default.
• W2049521952 isRetracted "false" @default.

• next